Clinical Trial Update: A Clinical Study to Investigate the Effect on Pain Relief of a Single Dose of JNJ-39439335 in Patients With Chronic Osteoarthritis Pain of the Knee [Phase 1]

View source ↗

Summary

This Phase 1 trial assessed the pain-relief effect of a single dose of JNJ-39439335 in adults with chronic knee osteoarthritis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Knee

Drugs mentioned

• JNJ-39439335

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Osteoarthritis, Knee | Phase 1 | Status: COMPLETED